Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study

BACKGROUND: Two-thirds of older people suffer from chronic pain and finding valid treatment options is essential. In this 1-yearlong investigation, we evaluated the efficacy and safety of prolonged-release oxycodone–naloxone (OXN-PR) in patients aged ≥70 (mean 81.7) years. METHODS: In this open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerriero, Fabio, Roberto, Anna, Greco, Maria Teresa, Sgarlata, Carmelo, Rollone, Marco, Corli, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844303/
https://www.ncbi.nlm.nih.gov/pubmed/27143857
http://dx.doi.org/10.2147/DDDT.S106025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844303/
https://www.ncbi.nlm.nih.gov/pubmed/27143857
http://dx.doi.org/10.2147/DDDT.S106025

Ejemplares similares